ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "CodeBreak200 And Elderly AML Survival"
Episode Synopsis
CodeBreak200: docetaxel vs. sotorasib in 2nd-line metastatic NSCLC (KRAS-G12C). A new safety signal emerges.
https://doi.org/10.1016/S0140-6736(23)00221-0
A new survival prediction model for elderly patients with AML not receiving intensive therapy.
https://doi.org/10.1002/cncr.34609
https://doi.org/10.1016/S0140-6736(23)00221-0
A new survival prediction model for elderly patients with AML not receiving intensive therapy.
https://doi.org/10.1002/cncr.34609
More episodes of the podcast OncoPharm
Bladder Cancer Updates & SC Amivantamab
18/12/2025
ASH 2025
11/12/2025
DPYD Deficiency Testing
04/12/2025
Cornucopia of Autumn Updates
26/11/2025
PGYNone: Dandelion Effect
20/11/2025
PGY1 Pathway: Road Trip!
13/11/2025
PGY2 Pathway: A Planned City
06/11/2025
Tale from the Crypt: Belantamab Mafodotin
30/10/2025
ESMO 2025
23/10/2025
IL-2
16/10/2025
In God we trust